LYVISPAH
NDC 64896-076, baclofen, granule, from Amneal Pharmaceuticals LLC.
- Product NDC
- 64896-076
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64896-076 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BACLOFEN5 mg/1
Pharmacologic classes
GABA A Agonists [MoA]; GABA B Agonists [MoA]; gamma-Aminobutyric Acid-ergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64896-076-09 | 64896007609 | 90 PACKET in 1 CARTON (64896-076-09) / 1 GRANULE in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f8992a56-9010-4c4b-84d5-ddcc3e2c3317
Use it
Look up 64896-076 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64896-076 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64896-076. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.